We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A
BIO

490 hedge funds and large institutions have $11.5B invested in Bio-Rad Laboratories Class A in 2020 Q4 according to their latest regulatory filings, with 76 funds opening new positions, 177 increasing their positions, 176 reducing their positions, and 57 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more funds holding in top 10

Funds holding in top 10: 5 → 7 (+2)

33% more first-time investments, than exits

New positions opened: 76 | Existing positions closed: 57

16% more capital invested

Capital invested by funds: $9.85B → $11.5B (+$1.61B)

3% more funds holding

Funds holding: 478 → 490 (+12)

1.14% more ownership

Funds ownership: 78.38% → 79.52% (+1.1%)

1% more repeat investments, than reductions

Existing positions increased: 177 | Existing positions reduced: 176

8% less call options, than puts

Call options by funds: $14.7M | Put options by funds: $16M

Holders
490
Holders Change
+12
Holders Change %
+2.51%
% of All Funds
8.67%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.12%
New
76
Increased
177
Reduced
176
Closed
57
Calls
$14.7M
Puts
$16M
Net Calls
-$1.25M
Net Calls Change
+$4.17M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$164M
2
BlackRock
BlackRock
New York
+$154M
3
HM
HealthCor Management
New York
+$79.8M
4
California Public Employees Retirement System
California Public Employees Retirement System
California
+$72.4M
5
UBS AM
UBS AM
Illinois
+$66.9M

Top Sellers

1
GQG Partners
GQG Partners
Florida
-$183M
2
American Century Companies
American Century Companies
Missouri
-$102M
3
ACM
Atlanta Capital Management
Georgia
-$89.1M
4
AQR Capital Management
AQR Capital Management
Connecticut
-$48.1M
5
Wells Fargo
Wells Fargo
California
-$42.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
RC
476
RegentAtlantic Capital
New Jersey
$2K -$29.6K -52 -2%
ADL
477
Asset Dedication LLC
California
$2K – – –
FGAM
478
Financial Gravity Asset Management
Texas
$2K +$2.28K +4 New
BSSFA
479
Baron Silver Stevens Financial Advisors
Florida
$2K +$2.85K +5 New
APA
480
American Portfolios Advisors
New York
$1.75K -$570 -1 -25%
UFF
481
USA Financial Formulas
Michigan
$1K -$1.09M -1,917 -100%
PFGIA
482
Patriot Financial Group Insurance Agency
Massachusetts
$1K -$1.14K -2 -50%
APC
483
Aspire Private Capital
North Carolina
$1K – – –
Fidelity International
484
Fidelity International
Bermuda
$1K – – –
GI
485
Gradient Investments
Minnesota
$1K – – –
APWA
486
Atlas Private Wealth Advisors
New Jersey
$1K +$1.14K +2 New
FHC
487
First Horizon Corporation
Tennessee
$1K +$1.14K +2 New
M
488
MOTCO
Texas
$1K +$1.14K +2 New
TWA
489
TCI Wealth Advisors
Arizona
$1K +$1.14K +2 New
WOSD
490
WFA of San Diego
California
$582 – – –
GQG Partners
491
GQG Partners
Florida
– -$183M -354,266 Closed
Renaissance Technologies
492
Renaissance Technologies
New York
– -$24.4M -47,400 Closed
TCM
493
Tang Capital Management
California
– -$20.6M -40,000 Closed
Hudson Bay Capital Management
494
Hudson Bay Capital Management
Connecticut
– -$7.73M -15,000 Closed
TA
495
Tamarack Advisers
California
– -$7.73M -15,000 Closed
CI
496
Cambiar Investors
Colorado
– -$5.32M -10,318 Closed
Qube Research & Technologies (QRT)
497
Qube Research & Technologies (QRT)
United Kingdom
– -$4.94M -9,585 Closed
Schroder Investment Management Group
498
Schroder Investment Management Group
United Kingdom
– -$3.59M -7,023 Closed
AIA
499
Avalon Investment & Advisory
Texas
– -$2.56M -4,969 Closed
Citadel Advisors
500
Citadel Advisors
Florida
– -$2.45M -4,748 Closed
18 19
20
21 22

BIO Hedge Fund Activity: Q4 2020 in Review

490 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q4 2020, worth a combined $11.5B — up 16% from $9.85B a quarter earlier.

Buyers outnumbered sellers: 76 funds opened new BIO positions and 57 closed out — a net gain of 19 holders — while 177 added to existing stakes and 176 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $164M. The largest seller was GQG Partners, exiting entirely with an estimated $183M sold.

  • 490 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q4 2020, up from 478 in Q3 2020.
  • Funds reported $11.5B of Bio-Rad Laboratories Class A stock for Q4 2020, up 16% quarter-over-quarter.
  • 76 funds opened new Bio-Rad Laboratories Class A positions in Q4 2020 and 57 closed out, a net change of +19 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q4 2020 was Fidelity Investments, an estimated $164M added.
  • The largest Bio-Rad Laboratories Class A seller in Q4 2020 was GQG Partners, an estimated $183M sold.

Based on aggregated 13F filings for Q4 2020.